Ralf Gold

Journal of Central Nervous System Disease

R. Gold, A. Chan, A. Salmen, 2022 .

Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions

J. Lünemann, A. Gass, C. Enzinger, 2021, Neurological Research and Practice.

Parkinson disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal–epidermal junction

R. Gold, D. Zillikens, D. Woitalla, 2016, The British journal of dermatology.

Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making?

T. Skripuletz, S. Meuth, Ralf Gold, 2024, Therapeutic advances in neurological disorders.

Disease-modifying treatment of secondary progressive multiple sclerosis

R. Gold, O. Hoffmann, Ralf Gold, 2021 .

Diroximel fumarate in patients with relapsing–remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study

F. Then Bergh, A. Wundes, R. Naismith, 2023, Multiple sclerosis.